It wasn’t too long ago that ultrasound was a roiling sea of innovation and new product releases, spurred by a rivalry among Diasonics, ATL, Hewlett-Packard (Agilent Technologies), and Acuson. Since these companies’ acquisition by GE, Philips, and Siemens, the waters have calmed. Supersonic Imagine plans to begin making some waves -- and soon.

If radiologists could design the perfect modality for guiding interventional procedures, the resulting technology would undoubtedly produce high-quality images without exposing patients to any ionizing radiation. So given the widespread availability of MRI, why are so many interventions still performed in the angiography suite?

Vacant hotel rooms are aplenty in Vienna this year and prices negotiable. In the month before ECR, one hotel chain even called former guests and congress participants directly and offered good deals.

The promise of increased efficiency and minimal x-ray dose were enough to convince Dr. Matthew Wallis to choose Sectra Medical Systems five years ago when setting up a digital breast screening program in the U.K.

Are there any limits to what can be achieved with new PACS technologies? Yes, of course. But sometimes it seems that the only restrictions are those imposed by the scope of the human imagination.

Coughing, shortness of breath, chest pain, chest tightness, and an abnormal breathing pattern are common indications of lung disease. The question is which one?

Crystal-ball gazing reached new levels at ECR on Saturday, when Prof. Dieter Enzmann took delegates on “a trip to radiology Tomorrowland,” as he referred to his W.C. Röntgen honorary lecture.

Yes, size does matter, but it is certainly not the only way to monitor the efficacy of cancer treatment. The way in which lesions are measured is extremely important as well, ECR delegates were told at a special focus session on the assessment of tumor response.

Prof. Hedvig Hricak told delegates during Friday’s opening lecture that they must learn from the words of Charles Darwin: embrace change and adapt.

Rheumatoid arthritis, which affects approximately 2.9 million people in Europe, can be difficult to differentiate from other degenerative arthritic conditions. Without an early diagnosis, however, it is impossible to assess the true effect of promising early intervention strategies. Could an alternative diagnostic imaging strategy be the answer?